{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T18:23:17Z","timestamp":1776450197953,"version":"3.51.2"},"reference-count":53,"publisher":"Elsevier BV","issue":"2","content-domain":{"domain":["em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal de Gyn\u00e9cologie Obst\u00e9trique et Biologie de la Reproduction"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1016\/j.jgyn.2013.11.011","type":"journal-article","created":{"date-parts":[[2014,1,20]],"date-time":"2014-01-20T09:00:33Z","timestamp":1390208433000},"page":"179-189","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Misoprostol\u00a0: utilisation hors AMM dans la prise en charge de l\u2019h\u00e9morragie du post-partum"],"prefix":"10.1016","volume":"43","author":[{"given":"A.","family":"Garrigue","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Pierre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jgyn.2013.11.011_bib0005","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1016\/S0140-6736(06)68397-9","article-title":"WHO analysis of causes of maternal deaths: a systematic review","volume":"367","author":"Khan","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.jgyn.2013.11.011_bib0010","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/S0140-6736(06)69380-X","article-title":"Maternal mortality: who, when, where, and why","volume":"368","author":"Ronsmans","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.jgyn.2013.11.011_bib0015","first-page":"105","article-title":"Community based investigation of causes of maternal mortality in rural and urban Zimbabwe","volume":"41","author":"Fawcus","year":"1995","journal-title":"Cent Afr J Med"},{"key":"10.1016\/j.jgyn.2013.11.011_bib0020","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.jgyn.2010.12.007","article-title":"The confidential enquiries into maternal deaths, 1996\u20132006\u00a0in France: what consequences for the obstetrical care?","volume":"40","author":"Bouvier-Colle","year":"2011","journal-title":"J Gynecol Obstet Biol Reprod"},{"key":"10.1016\/j.jgyn.2013.11.011_bib0025","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1136\/bmj.297.6659.1295","article-title":"The Bristol third stage trial: active versus physiological management of third stage of labour","volume":"297","author":"Prendiville","year":"1988","journal-title":"BMJ"},{"key":"10.1016\/j.jgyn.2013.11.011_bib0030","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/0028-2243(92)90069-B","article-title":"For a systematic policy of i.v. oxytocin inducted placenta deliveries in a unit where a fairly active management of third stage of labour is yet applied: results of a controlled trial","volume":"43","author":"Pierre","year":"1992","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.jgyn.2013.11.011_bib0035","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/S0140-6736(97)09409-9","article-title":"Active versus expectant management of third stage of labour: the Hinchingbrookerandomised controlled trial","volume":"351","author":"Rogers","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.jgyn.2013.11.011_bib0040","series-title":"WHO Recommendations for the Prevention of Postpartum Haemorrhage","author":"WHO, DoMps","year":"2007"},{"key":"10.1016\/j.jgyn.2013.11.011_bib0045","unstructured":"Abalos E.\u00a0Choix des ut\u00e9rotoniques dans la prise en charge active de la d\u00e9livrance\u00a0: commentaire de la BSG (derni\u00e8re r\u00e9vision\u00a0: 2\u00a0mars 2009). Biblioth\u00e8que de Sant\u00e9 G\u00e9n\u00e9sique de l\u2019OMS\u00a0; Gen\u00e8ve: Organisation mondiale de la Sant\u00e9."},{"key":"10.1016\/j.jgyn.2013.11.011_bib0050","first-page":"CD000007","article-title":"Active versus expectant management in the third stage of labour","author":"Prendiville","year":"2000","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jgyn.2013.11.011_bib0055","series-title":"WHO Model List of Essential Medicines 17th edition [online]","author":"World Health Organization","year":"2011"},{"key":"10.1016\/j.jgyn.2013.11.011_bib0060","first-page":"CD000494","article-title":"Prostaglandins for preventing postpartum haemorrhage","volume":"3","author":"G\u00fclmezoglu","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jgyn.2013.11.011_bib0065","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.ijgo.2007.09.012","article-title":"Prevention of postpartum haemorrhage with misoprostol","volume":"99","author":"Alfirevic","year":"2007","journal-title":"Int J Gyneacol Obstet"},{"key":"10.1016\/j.jgyn.2013.11.011_bib0070","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1111\/j.1471-0528.2010.02567.x","article-title":"What measured blood loss tells us about post-partum bleeding: a systematic review","volume":"117","author":"Sloan","year":"2010","journal-title":"BJOG"},{"key":"10.1016\/j.jgyn.2013.11.011_bib0075","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/j.bpobgyn.2008.08.005","article-title":"Misoprostol for the prevention and treatment of postpartum haemorrhage","volume":"22","author":"Hofmeyr","year":"2008","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"10.1016\/j.jgyn.2013.11.011_bib0080","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1136\/bmj.331.7519.723","article-title":"Effect of sublingual misoprostol on severe postpartum hemorrhage in a primary health centre in Guinea-Bissau: randomized double blind clinical trial","volume":"331","author":"H\u00f8j","year":"2005","journal-title":"BMJ"},{"key":"10.1016\/j.jgyn.2013.11.011_bib0085","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1016\/S0140-6736(06)69522-6","article-title":"Oral misoprostol in preventing postpartum haemorrhage in resource-poor communities: a randomised controlled trial","volume":"368","author":"Derman","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.jgyn.2013.11.011_bib0090","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1111\/j.1471-0528.2010.02807.x","article-title":"Administration of misoprostol by trained traditional birth attendants to prevent postpartum haemorrhage in homebirths in Pakistan: a randomized placebo-controlled trial","volume":"118","author":"Mobeen","year":"2011","journal-title":"BJOG"},{"key":"10.1016\/j.jgyn.2013.11.011_bib0095","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1517\/13543784.2012.647405","article-title":"Misoprostol for the prevention and treatment of postpartum hemorrhage","volume":"21","author":"Sheldon","year":"2012","journal-title":"Expert Opin Invest Drugs"},{"key":"10.1016\/j.jgyn.2013.11.011_bib0100","first-page":"CD000494","article-title":"Prostaglandins for preventing postapartum haemorrhage","volume":"8","author":"Tun\u00e7alp","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jgyn.2013.11.011_bib0105","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.ijgo.2012.03.001","article-title":"FIGO Guidelines: prevention and treatment of postpartum hemorrhage in low-resource settings","volume":"117","author":"Lalonde","year":"2012","journal-title":"Int J Gynecol Obstet"},{"key":"10.1016\/j.jgyn.2013.11.011_bib0110","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.ijgo.2009.06.007","article-title":"Comparison of sublingual misoprostol, intravenous oxytocin, and intravenous methylergometrine in active management of the third stage of labor","volume":"107","author":"Singh","year":"2009","journal-title":"Int J Gynecol Obstet"},{"key":"10.1016\/j.jgyn.2013.11.011_bib0115","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.ijgo.2011.09.016","article-title":"Sublingual misoprostol versus intramuscular oxytocin for prevention of post-partum hemorrhage in low-risk women","volume":"116","author":"Chaudhuri","year":"2012","journal-title":"Int J Gynecol Obstet"},{"key":"10.1016\/j.jgyn.2013.11.011_bib0120","first-page":"207","article-title":"Oral misoprostol versus intramuscular oxytocin in the active management of the third stage of labour","volume":"51","author":"Afolabi","year":"2010","journal-title":"Singapour Med J"},{"key":"10.1016\/j.jgyn.2013.11.011_bib0125","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.ijgo.2006.12.016","article-title":"Misoprostol versus oxytocin for the reduction of post-partum blood loss","volume":"97","author":"Baskett","year":"2007","journal-title":"Int J Gynecol Obstet"},{"key":"10.1016\/j.jgyn.2013.11.011_bib0130","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1159\/000095498","article-title":"A double-blind randomized controlled trial of oral misoprostol and intramuscular syntometrine in the management of the third stage of labor","volume":"63","author":"Ng","year":"2007","journal-title":"Gynecol Obstet Invest"},{"key":"10.1016\/j.jgyn.2013.11.011_bib0135","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ijgo.2005.08.026","article-title":"Oral misoprostol in the third stage of labor","volume":"92","author":"Zachariah","year":"2006","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.jgyn.2013.11.011_bib0140","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0020-7292(01)00498-2","article-title":"Misoprostol versus oxytocin in the third stage of labor","volume":"75","author":"Kundodyiwa","year":"2001","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.jgyn.2013.11.011_bib0145","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1111\/j.1471-0528.2000.tb11109.x","article-title":"A double-blind placebo controlled randomized trial of misoprostol and oxytocin in the management of the third stage of labour","volume":"107","author":"Walley","year":"2000","journal-title":"BJOG"},{"key":"10.1016\/j.jgyn.2013.11.011_bib0150","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijgo.2004.05.016","article-title":"Sublingual misoprostol versus methylergometrine for active management of the third stage of labor","volume":"87","author":"Vimala","year":"2004","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.jgyn.2013.11.011_bib0155","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/S0140-6736(01)05835-4","article-title":"WHO multicentre randomized study of misoprostol in the management of the third stage of labour","volume":"358","author":"G\u00fclmezoglu","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.jgyn.2013.11.011_bib0160","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1067\/mob.2002.126293","article-title":"Is rectal misoprostol really effective in the treatment of third stage of labor? A randomized controlled trial","volume":"187","author":"Caliskan","year":"2002","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jgyn.2013.11.011_bib0165","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/S0029-7844(03)00077-2","article-title":"Oral misoprostol for the third stage of labor: a randomized controlled trial","volume":"101","author":"Caliskan","year":"2003","journal-title":"Obstet Gynaecol"},{"key":"10.1016\/j.jgyn.2013.11.011_bib0170","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.ijgo.2010.08.023","article-title":"A double-blind, randomized, placebo-controlled trial of misoprostol and routine uterotonics for the prevention of postpartum hemorrhage","volume":"112","author":"Fawole","year":"2011","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.jgyn.2013.11.011_bib0175","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.ijgo.2010.08.019","article-title":"Administration of 400\u00a0ug of misoprostol to augment routine active management of the third stage of labor","volume":"112","author":"Hofmeyr","year":"2011","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.jgyn.2013.11.011_bib0180","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1111\/j.1471-0528.2012.03341.x","article-title":"Prevention of post-partumhaemorrhage with sublingual misoprostol or oxytocin: a double blind randomisedcontrlled trial","volume":"119","author":"Bellad","year":"2012","journal-title":"BJOG"},{"key":"10.1016\/j.jgyn.2013.11.011_bib0185","first-page":"191","article-title":"Does the route of administration of misoprostol make a difference? The uterotonic effect and side effects of misoprostol given by different routes after vaginal delivery","volume":"131","author":"Chong","year":"2004","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jgyn.2013.11.011_bib0190","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1093\/humrep\/17.2.332","article-title":"Pharmacokinetics of different routes of administration of misoprostol","volume":"17","author":"Tang","year":"2002","journal-title":"Hum Reprod"},{"key":"10.1016\/j.jgyn.2013.11.011_bib0195","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/S0029-7844(97)00111-7","article-title":"Absorption kinetics of misoprostol with oral or vaginal administration","volume":"90","author":"Zieman","year":"1997","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jgyn.2013.11.011_bib0200","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1111\/j.1471-0528.2010.02564.x","article-title":"High fever following postpartum administration of sublingual misoprostol","volume":"117","author":"Durocher","year":"2010","journal-title":"BJOG"},{"key":"10.1016\/j.jgyn.2013.11.011_bib0205","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1046\/j.1471-0528.2002.t01-1-02019.x","article-title":"Side effects of misoprostol during the first 24hours after administration in the third stage of labour","volume":"109","author":"Lumbiganon","year":"2002","journal-title":"BJOG"},{"key":"10.1016\/j.jgyn.2013.11.011_bib0210","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1080\/14767050802452309","article-title":"Side effects of oral misoprostol for the prevention of post-partum haemorrhage: results of a community-based randomized controlled trial in rural India","volume":"22","author":"Patted","year":"2009","journal-title":"J Matern Fetal Neonatal Med"},{"key":"10.1016\/j.jgyn.2013.11.011_bib0215","first-page":"CD003249","article-title":"Treatment for primary postpartum haemorrhage","volume":"1","author":"Mousa","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jgyn.2013.11.011_bib0220","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/S0140-6736(09)61924-3","article-title":"Treatment of post-partum haemorrhage with sublingual misoprostol versus oxytocin in women not exposed to oxytocin during labour: a double-blind, randomised, non-inferiority trial","volume":"375","author":"Winikoff","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.jgyn.2013.11.011_bib0225","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0140-6736(09)61923-1","article-title":"Treatment of post-partum haemorrhage with sublingual misoprostol versus oxytocin in women receiving prophylactic oxytocin: a double-blind, randomised, non-inferiority trial","volume":"375","author":"Blum","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.jgyn.2013.11.011_bib0230","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/1471-2393-8-40","article-title":"Misoprostol in addition to routine treatment of postpartum hemorrhage: a hospital-based randomized controlled-trial in Karachi, Pakistan","volume":"8","author":"Zuberi","year":"2008","journal-title":"BMC Pregnancy Childbirth"},{"key":"10.1016\/j.jgyn.2013.11.011_bib0235","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1016\/S0140-6736(10)60348-0","article-title":"misoprostol as an adjunct to standard uterotonics for treatment of post-partum haemorrhage: a multicentre, double-blind randomized trial","volume":"375","author":"Widmer","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.jgyn.2013.11.011_bib0240","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1111\/j.1471-0528.2004.00217.x","article-title":"Misoprostol in the treatment of postpartum haemorrhage in addition to routine management: a placebo randomized controlled trial","volume":"111","author":"Walraven","year":"2004","journal-title":"BJOG"},{"key":"10.1016\/j.jgyn.2013.11.011_bib0245","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1471-2393-4-16","article-title":"Misoprostol for treating postpartum haemorrhage: a randomized controlled trial","volume":"4","author":"Hofmeyr","year":"2004","journal-title":"BMC Pregnancy Childbirth"},{"key":"10.1016\/j.jgyn.2013.11.011_bib0250","first-page":"CD008982","article-title":"Postpartum misoprostol for preventing maternal mortality and morbidity","volume":"7","author":"Hofmeyr","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jgyn.2013.11.011_bib0255","first-page":"CD009336","article-title":"Advance misoprostol distribution for preventing and treating postpartum haemorrhage","volume":"2","author":"Oladapo","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jgyn.2013.11.011_bib0260","doi-asserted-by":"crossref","first-page":"666","DOI":"10.2471\/BLT.08.055715","article-title":"Misoprostol to prevent and treat postpartum haemorrhage: a systematic review and meta-analysis of maternal deaths and dose-related effects","volume":"87","author":"Hofmeyr","year":"2009","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.jgyn.2013.11.011_bib0265","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/1471-2393-12-65","article-title":"Dose and side effects of sublingual misoprostol for treatment of postpartum hemorrhage: what difference do they make?","volume":"12","author":"Le\u00f3n","year":"2012","journal-title":"BMC Pregnancy Childbirth"}],"container-title":["Journal de Gyn\u00e9cologie Obst\u00e9trique et Biologie de la Reproduction"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0368231513003591?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0368231513003591?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,7]],"date-time":"2018-10-07T02:53:59Z","timestamp":1538880839000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0368231513003591"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2]]},"references-count":53,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,2]]}},"alternative-id":["S0368231513003591"],"URL":"https:\/\/doi.org\/10.1016\/j.jgyn.2013.11.011","relation":{},"ISSN":["0368-2315"],"issn-type":[{"value":"0368-2315","type":"print"}],"subject":[],"published":{"date-parts":[[2014,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Misoprostol\u00a0: utilisation hors AMM dans la prise en charge de l\u2019h\u00e9morragie du post-partum","name":"articletitle","label":"Article Title"},{"value":"Journal de Gyn\u00e9cologie Obst\u00e9trique et Biologie de la Reproduction","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jgyn.2013.11.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Published by Elsevier Masson SAS","name":"copyright","label":"Copyright"}]}}